Physician profile
Petr Bezdicek
NPI 1528047057
$1,888.38
in general payments reported to CMS, 2019-2025
8 companies · $656 in 2025
The $656 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2021: $269 · 2022: $250 · 2023: $117 · 2024: $264 · 2025: $656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $886 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $885.94 |
| Education | $151.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,370.89 | 2019-2025 | Tezspire, Fasenra |
| Amgen INC. | $159.00 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $123.72 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $98.99 | 2023 | Uptravi, Opsumit |
| Glaxosmithkline, LLC. | $88.13 | 2021-2025 | Nucala |
| Bayer Healthcare Pharmaceuticals INC. | $18.28 | 2023 | |
| United Therapeutics Corporation | $15.00 | 2021 | |
| Genzyme Corporation | $14.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Petr Bezdicek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.